|
Radiopharmaceuticals, Dosimetry, and Tracer Kinetics |
|
|
1 | (28) |
|
Part I: An Introduction to Nuclear Medicine |
|
|
1 | (4) |
|
Part II: Production of Radionuclides and Radiopharmaceutical Dosimetry |
|
|
5 | (5) |
|
Part III: Tracer Kinetics |
|
|
10 | (15) |
|
|
|
25 | (4) |
|
Instrumentation and Technical Considerations in Planar and SPECT Imaging |
|
|
29 | (17) |
|
|
|
29 | (4) |
|
Quality Assurance in Cardiac Nuclear Imaging: Detection Efficiency or Sensitivity |
|
|
33 | (5) |
|
|
|
38 | (1) |
|
Applications of Computers in Nuclear Cardiology |
|
|
39 | (1) |
|
Thallium 201 Planar Imaging Methodology |
|
|
40 | (1) |
|
Technetium 99m Sestamibi Imaging Methodology |
|
|
41 | (2) |
|
Technetium 99m Teboroxime Imaging Methodology |
|
|
43 | (1) |
|
Principles of Single-Photon Emission Computed Tomography: Acquisition and Processing |
|
|
43 | (3) |
|
Exercise Testing and Physiology |
|
|
46 | (27) |
|
|
|
46 | (4) |
|
|
|
50 | (1) |
|
|
|
50 | (1) |
|
General Considerations for Exercise Testing |
|
|
51 | (2) |
|
|
|
53 | (9) |
|
Results of Exercise Testing |
|
|
62 | (11) |
|
Exercise Perfusion Imaging in Coronary Artery Disease: Physiology and Diagnosis |
|
|
73 | (71) |
|
Anatomic and Physiologic Basis of Cardiac Imaging |
|
|
74 | (2) |
|
Methods for Assessing Coronary Blood Flow in Humans |
|
|
76 | (2) |
|
Technical Aspects of Exercise Perfusion Scintigraphy |
|
|
78 | (3) |
|
Indications for Exercise Perfusion Imaging |
|
|
81 | (1) |
|
Diagnosis of CAD by Exercise Scintigraphy |
|
|
82 | (50) |
|
Detection of Silent Myocardial Ischemia by Myocardial Perfusion Imaging |
|
|
132 | (12) |
|
|
|
144 | (75) |
|
Gated Versus First-Pass RNA |
|
|
145 | (2) |
|
Ejection Fraction Reliability and Reproductivity |
|
|
147 | (10) |
|
Peripheral Circulatory Dynamics |
|
|
157 | (1) |
|
|
|
157 | (10) |
|
|
|
167 | (21) |
|
Effect of Drugs on Ventricular Function |
|
|
188 | (13) |
|
Simultaneous Assessment of Myocardial Function and Perfusion |
|
|
201 | (18) |
|
Pharmacologic Stress Testing and Other Alternative Techniques in the Diagnosis of Coronary Artery Disease |
|
|
219 | (23) |
|
Pharmacologic ``Stress'' Myocardial Perfusion Scintigraphy |
|
|
220 | (14) |
|
Pharmacologic Stress in Combination with Radionuclide Angiography |
|
|
234 | (2) |
|
Atrial Pacing Stress as an Adjunct to Cardiac Radionuclide Imaging |
|
|
236 | (1) |
|
Induction of Coronary Vasoconstriction in Combination with Myocardial Perfusion Scintigraphy |
|
|
236 | (1) |
|
Cold Pressor Stress as an Adjunct to Myocardial Perfusion Scintigraphy |
|
|
236 | (6) |
|
|
|
242 | (37) |
|
|
|
242 | (1) |
|
|
|
243 | (1) |
|
Clinical Models in Risk Stratification |
|
|
243 | (1) |
|
Risk Assessment in Patients with Silent Ischemia |
|
|
244 | (1) |
|
Risk Assessment in Patients with Stable Symptoms: Use of Perfusion Imaging |
|
|
245 | (9) |
|
Risk Assessment in Patients with Stable Symptoms: Use of Radionuclide Angiography |
|
|
254 | (3) |
|
Risk Assessment After Coronary Artery Bypass Surgery and Coronary Angioplasty |
|
|
257 | (1) |
|
Risk Assessment After Acute Myocardial Infarction |
|
|
257 | (11) |
|
Risk Assessment in Patients with Unstable Angina |
|
|
268 | (1) |
|
Risk Assessment Before Major Noncardiac Surgery |
|
|
269 | (10) |
|
Nuclear Imaging After Coronary Revascularization |
|
|
279 | (26) |
|
Myocardial Perfusion Imaging and Coronary Revascularization |
|
|
279 | (18) |
|
Radionuclide Angiography and Coronary Revascularization |
|
|
297 | (4) |
|
Use of Radionuclide Imaging in Risk Assessment After Coronary Artery Revascularization |
|
|
301 | (4) |
|
|
|
305 | (22) |
|
|
|
305 | (2) |
|
Patient Selection for Viability Studies |
|
|
307 | (1) |
|
Methods for Detection of Viability |
|
|
308 | (11) |
|
Factors Affecting Recovery of LV Function |
|
|
319 | (2) |
|
|
|
321 | (6) |
|
Scintigraphic Techniques in Acute Ischemic Syndromes |
|
|
327 | (30) |
|
|
|
327 | (13) |
|
Myocardial Perfusion Imaging in Acute Myocardial Infarction |
|
|
340 | (11) |
|
Thallium 201 and Technetium 99m Sestamibi in Unstable Angina |
|
|
351 | (6) |
|
Scintigraphic Imaging in Other Types of Heart Disease |
|
|
357 | (49) |
|
|
|
358 | (15) |
|
Hypertrophic Cardiomyopathy |
|
|
373 | (2) |
|
Other Types of Cardiomyopathies |
|
|
375 | (2) |
|
|
|
377 | (1) |
|
|
|
377 | (5) |
|
|
|
382 | (4) |
|
Doxorubicin Cardiotoxicity |
|
|
386 | (1) |
|
|
|
387 | (1) |
|
Effect of Angiographic Contrast Medium |
|
|
387 | (1) |
|
Effect of Intra-aortic Balloon Pumping and Support Devices |
|
|
388 | (1) |
|
|
|
389 | (2) |
|
Changes in Cardiac Rhythm or Conduction |
|
|
391 | (3) |
|
|
|
394 | (1) |
|
|
|
394 | (12) |
|
Other Nuclear Imaging Modalities |
|
|
406 | (15) |
|
Single-Photon Metabolic Imaging |
|
|
406 | (4) |
|
Tracers of Cardiac Innervation and Receptors |
|
|
410 | (3) |
|
Clot Detection by Imaging Techniques |
|
|
413 | (1) |
|
Indium 111-Labeled Lymphocyte Imaging to Detect Cardiac Rejection |
|
|
413 | (1) |
|
|
|
414 | (1) |
|
The Multiwire Gamma Camera |
|
|
414 | (3) |
|
Imaging of Tracer-Labeled Ischemia or Hypoxia |
|
|
417 | (4) |
|
Alternative Noninvasive Imaging Techniques: Which Test, When, and Why? |
|
|
421 | (10) |
|
Comparison of Noninvasive Techniques |
|
|
421 | (3) |
|
|
|
424 | (1) |
|
Risk Assessment of Patients with CAD |
|
|
424 | (3) |
|
Detection of CAD in Patients with Aortic Valve Disease or Hypertrophic Cardiomyopathy |
|
|
427 | (1) |
|
Assessment of Cardiotoxicity |
|
|
427 | (1) |
|
Detection of Left-to-Right Intracardiac Shunts |
|
|
427 | (1) |
|
Detection and Quantitation of Valvular Regurgitation |
|
|
427 | (1) |
|
Detection and Localization of Bypass Tracts in Patients with Wolff-Parkinson-White Syndrome |
|
|
427 | (1) |
|
Assessment of LV Function and Right Ventricular Function |
|
|
427 | (1) |
|
Cost-Effectiveness Analysis |
|
|
427 | (4) |
| Appendix A Laboratory Organization |
|
431 | (11) |
| Appendix B Specific Training Requirements for Nuclear Cardiology |
|
442 | (1) |
| Index |
|
443 | |
Shopping Cart
